![Doit L. Koppler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Doit L. Koppler
Directeur en chef des Investissements chez
Third Security LLC
Profil
Doit L.
Koppler currently works at Oxitec Insect Holdings Ltd., as Director from 2020, Third Security LLC, as Chief Investment Officer, and The American Institute of Certified Public Accountants, as Member.
Mr. Koppler also formerly worked at New River Funds, as Chairman & Chief Executive Officer, Transgenomic, Inc., as Independent Director from 2010 to 2017, IntelliMat, Inc., as Director in 2008, Vital Diagnostics Holding Corp., as Treasurer, Director & Vice President from 2006 to 2012, Precipio, Inc., as Board of Directors from 2010 to 2017, Eleszto Genetika, Inc., as Treasurer & Board of Directors, Ernst & Young LLP, as Manager in 1992, New River Advisers LLC, as Chief Investment Officer, General Injectables & Vaccines, Inc., as Vice President & Controller in 2000, and GIV Holdings, Inc., as Vice President & Controller in 2000.
Mr. Koppler received his undergraduate degree from Salem International University.
Postes actifs de Doit L. Koppler
| Sociétés | Poste | Début |
|---|---|---|
Third Security LLC
 Third Security LLC Investment ManagersFinance Third Security invests in companies located across the globe. The firm focuses on the biotechnology sector. It provides financing for early and later stage capital requirements. | Directeur en chef des Investissements | - |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | 18/04/2011 |
Oxitec Insect Holdings Ltd.
 Oxitec Insect Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | 17/04/2020 |
Anciens postes connus de Doit L. Koppler
| Sociétés | Poste | Fin |
|---|---|---|
Transgenomic, Inc.
 Transgenomic, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine in the detection and treatment of cancer and inherited diseases | Directeur/Membre du Conseil | 28/06/2017 |
| PRECIPIO, INC. | Directeur/Membre du Conseil | 01/06/2017 |
Vital Diagnostics Holding Corp.
 Vital Diagnostics Holding Corp. Medical SpecialtiesHealth Technology Produces and distributes in vitro diagnostic equipment and reagents | Directeur/Membre du Conseil | 01/01/2012 |
IntelliMat, Inc.
 IntelliMat, Inc. Movies/EntertainmentConsumer Services Specializes in digital video programming solutions | Directeur/Membre du Conseil | 01/07/2008 |
New River Funds
 New River Funds Investment Trusts/Mutual FundsMiscellaneous An open-end mutual fund/MUT | Président | - |
Formation de Doit L. Koppler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine in the detection and treatment of cancer and inherited diseases | Health Technology |
New River Funds
New River Funds Investment Trusts/Mutual FundsMiscellaneous An open-end mutual fund/MUT | Miscellaneous |
New River Advisers LLC
 New River Advisers LLC New River Advisers LLC is a specialty pharmaceutical company that develops novel pharmaceuticals to improve the effectiveness of widely-prescribed drugs in large and growing markets. The company utilizes their proprietary Carrierwave technology to create new molecular entities that are derivatives of public domain actives. The company's lead product candidates in clinical development are amphetamine and amphethethetidine derivatives that are expected to provide improved alternatives to currently marketed drugs. The company is also researching a drug for the treatment of chronic pain and primary hypothyroidism. The company is located in the US. | |
IntelliMat, Inc.
IntelliMat, Inc. Movies/EntertainmentConsumer Services Specializes in digital video programming solutions | Consumer Services |
Third Security LLC
Third Security LLC Investment ManagersFinance Third Security invests in companies located across the globe. The firm focuses on the biotechnology sector. It provides financing for early and later stage capital requirements. | Finance |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
General Injectables & Vaccines, Inc.
 General Injectables & Vaccines, Inc. Medical DistributorsDistribution Services Supplier of vaccines | Distribution Services |
Salem International University
 Salem International University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vital Diagnostics Holding Corp.
Vital Diagnostics Holding Corp. Medical SpecialtiesHealth Technology Produces and distributes in vitro diagnostic equipment and reagents | Health Technology |
GIV Holdings, Inc. | |
Oxitec Insect Holdings Ltd.
Oxitec Insect Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Precipio, Inc.
 Precipio, Inc. Medical/Nursing ServicesHealth Services Provides medical diagnostics services | Health Services |
ILH Holdings, Inc.
 ILH Holdings, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
